Cargando…
Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma
Immune checkpoint inhibitors (ICIs) are the key drugs used in patients with non‐small cell lung cancer (NSCLC). However, anti‐PD‐1 therapy might worsen chronic infection by reactivating the immune response to infectious diseases. Here, we describe a case of successful treatment with nivolumab in a p...
Autores principales: | Furuya, Naoki, Kojima, Koji, Marushima, Hideki, Kakinuma, Kazutaka, Tsunoda, Akihito, Koda, Eriko, Tsuruoka, Hajime, Nishida, Kohei, Inoue, Takeo, Saji, Hisashi, Mineshita, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605990/ https://www.ncbi.nlm.nih.gov/pubmed/32941695 http://dx.doi.org/10.1111/1759-7714.13662 |
Ejemplares similares
-
Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer
por: Furuya, Naoki, et al.
Publicado: (2020) -
Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer
por: Kakinuma, Kazutaka, et al.
Publicado: (2017) -
Successful use of linezolid for refractory Mycobacterium abcessus infection: A case report
por: Inoue, Teppei, et al.
Publicado: (2017) -
Untreated Squamous Cell Lung Carcinoma May Contribute to the Occurrence of Hemophagocytic Syndrome
por: Koda, Eriko, et al.
Publicado: (2021) -
Thoracic mesenchymal malignant tumors and programed cell death ligand‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas
por: Otsubo, Kanji, et al.
Publicado: (2021)